Regulation - volasertib, Boehringer Ingelheim

Filter

Popular Filters

Boehringer Ingelheim gets Breakthrough designation for leukemia candidate

17-09-2013

German pharma major Boehringer Ingelheim has gained Breakthrough Therapy Designation from the US Food…

Boehringer IngelheimEuropeOncologyPharmaceuticalRegulationvolasertib

Parexel

Parexel

Back to top